Printer Friendly

TWO MILLION SHARES OF CALGENE COMMON STOCK OFFERED AT $11.25 PER SHARE

TWO MILLION SHARES OF CALGENE COMMON STOCK OFFERED AT $11.25 PER SHARE
    DAVIS, Calif., March 19 /PRNewswire/ -- Calgene, Inc. (NASDAQ-NMS: CGNE) announced that it completed a public offering of 2,000,000 shares of its common stock in an underwriting led by PaineWebber Incorporated and Piper, Jaffray & Hopwood Incorporated at a price of $11.25 per share.  The underwriters have been granted a 30 day option to purchase up to an additional 300,000 shares to cover over- allotments.
    Calgene is a biotechnology company that is developing a portfolio of genetically engineered plants and plant products for the seed, food and oleochemical industries.
    This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration of qualification under the securities laws of any such state.
    -0-                          3/19/92
    /CONTACT:  Daniel O. Wagster, II, chief financial officer of Calgene, 916-753-6313/
    (CGNE) CO:  Calgene Inc. ST:  California IN:  MTC SU:  OFR SM -- NY036 -- 9595 03/19/92 10:37 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 19, 1992
Words:191
Previous Article:FORD IN INDIANA - 1991
Next Article:NEW PRESIDENT NAMED FOR HEALTH CARE VENDOR AUTOMATED BENEFIT SERVICES, INC.
Topics:


Related Articles
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION ANNOUNCES EXERCISE OF OPTION AND INCLUSION IN TSE 300 COMPOSITE INDEX
INTERNATIONAL MUREX TECHNOLOGIES CORPORATION CLOSES EURO-EQUITY OPTION FOR NEW COMMON SHARES
CALGENE PLANS STOCK OFFERING
CALGENE ANNOUNCES FIRST HALF RESULTS
CALGENE ANNOUNCES THIRD QUARTER RESULTS; FDA FOOD BIOTECHNOLOGY GUIDELINES IMMINENT
CALGENE CALLS CONVERTIBLE PREFERRED STOCK FOR REDEMPTION
CALGENE ISSUES COMMON SHARES UPON CONVERSION OF PREFERRED STOCK
CALGENE FILES FOR OFFERING OF 2,000,000 SHARES
CALGENE ANNOUNCES OFFERING OF 3,000,000 SHARES
Calgene Announces First Quarter Results

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters